Tag: Survival

According to the CDC, approximately 6.2 million adults in the United States suffer from heart failure, a progressive condition where the heart cannot pump enough blood to meet the body's needs. Fortunately, a combination of modern pharmacological treatments, known as guideline-directed medical therapy, have been proven to significantly improve prognosis, answering the question: "What drugs keep you alive in heart failure?".

In idiopathic pulmonary fibrosis (IPF), an aggressive disease with a typical prognosis of only 3 to 5 years, treatments that can slow progression are critically important. While not a cure, antifibrotic medications like nintedanib have significantly altered this outlook by reducing the rate of lung function decline. The question of how long does nintedanib extend life is a complex one, with answers drawn from both controlled clinical trials and long-term observational studies.